My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Spyre Therapeutics, Inc.
Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in Rheumatic Diseases
September 15, 2025
From
Spyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
SYRE
Spyre Therapeutics to Participate in Stifel 2025 Virtual Immunology and Inflammation Forum
September 08, 2025
From
Spyre Therapeutics, Inc.
Via
GlobeNewswire
Spyre Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 05, 2025
From
Spyre Therapeutics, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.